Production (Stage)
Akebia Therapeutics, Inc.
AKBA
$2.86
$0.031.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 113.37M | 51.87M | 34.02M | 39.50M | 41.96M |
| Total Receivables | 61.54M | 34.37M | 32.17M | 29.77M | 26.62M |
| Inventory | 19.73M | 16.24M | 20.49M | 23.87M | 25.53M |
| Prepaid Expenses | 1.22M | 4.03M | 7.23M | 11.63M | 14.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.92M | 7.32M | 6.21M | 7.33M | 4.81M |
| Total Current Assets | 203.78M | 113.83M | 100.12M | 112.10M | 112.94M |
|
|
|||||
| Total Current Assets | 203.78M | 113.83M | 100.12M | 112.10M | 112.94M |
| Net Property, Plant & Equipment | 9.02M | 10.42M | 11.83M | 13.26M | 14.66M |
| Long-term Investments | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M |
| Goodwill | 59.04M | 59.04M | 59.04M | 59.04M | 59.04M |
| Total Other Intangibles | -- | 0.00 | 9.01M | 18.02M | 27.03M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.34M | 37.38M | 27.13M | 17.78M | 11.79M |
| Total Assets | 310.19M | 220.67M | 207.14M | 220.20M | 225.48M |
|
|
|||||
| Total Accounts Payable | 12.66M | 15.18M | 13.49M | 10.11M | 11.88M |
| Total Accrued Expenses | 39.78M | 33.27M | 28.17M | 27.23M | 26.77M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.55M | 9.71M | 7.52M | 7.19M | 7.07M |
| Total Finance Division Other Current Liabilities | 25.24M | 22.75M | 16.52M | 62.77M | 20.77M |
| Total Other Current Liabilities | 25.24M | 22.75M | 16.52M | 62.77M | 20.77M |
| Total Current Liabilities | 91.23M | 80.91M | 65.71M | 107.30M | 66.49M |
|
|
|||||
| Total Current Liabilities | 91.23M | 80.91M | 65.71M | 107.30M | 66.49M |
| Long-Term Debt | 179.92M | 175.47M | 90.74M | 91.13M | 83.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.12M | 3.55M | 4.94M | 6.30M | 7.64M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.33M | 9.93M | 96.16M | 49.22M | 94.97M |
| Total Liabilities | 285.60M | 269.86M | 257.54M | 253.95M | 252.74M |
|
|
|||||
| Common Stock & APIC | 1.70B | 1.63B | 1.61B | 1.60B | 1.60B |
| Retained Earnings | -1.67B | -1.68B | -1.66B | -1.64B | -1.63B |
| Treasury Stock & Other | 6.00K | 6.00K | 6.00K | 6.00K | 6.00K |
| Total Common Equity | 24.58M | -49.19M | -50.40M | -33.75M | -27.26M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 24.58M | -49.19M | -50.40M | -33.75M | -27.26M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 24.58M | -49.19M | -50.40M | -33.75M | -27.26M |
|
|
|||||